Clinical outcome after pulmonary metastasectomy from primary hepatocellular carcinoma: Analysis of prognostic factors

Table 2 Clinical findings of 16 patients with HCC who underwent pulmonary metastasectomy

Clinical findings	Number of patients (n = 16)	Percents of patients (%)
Gender: male/female	14/2	87.5/12.5
Age at pulmonary resection (yr)	45 ± 9.8 (31-67)1
Etiology of liver diseases
Cirrhosis + HCC + HBV	5	31.3
Cirrhosis + HCC	2	12.5
Alcoholic liver disease + HCC	2	12.5
HCC + HBV	7	43.8
Maximal diameter of lung lesions	13 ± 10 (3-50 mm)
Treatment of primary lesion2
Hepatic resection	5	31.3
Liver transplantation	7	43.8
Local therapy	5	31.3
Treatment of lung lesions2
Thoracoscopic resection	15	93.8
Open wedge resection	9	56.3
Lobectomy	1	6.3
Tomotherapy after recurrence	2	12.5
Maximal diameter of lung lesions	13 ± 10 (3-50 mm)
Number of lung metastasectomy
1	9	56.2
≥ 2	7	43.8
HBV hepatitis
Yes	12	75.0
No	4	25.0
HCC pathologic finding
Well differentiated	7	43.8
Poorly differentiated	9	56.2
Alpha fetoprotein
> 20 ng/mL	8	50.0
< 20 ng/mL	8	50.0
Liver cirrhosis
Yes	7	43.8
No	9	56.3

¹mean ± SD (range);

²Multiple therapies were performed.